News New Breakthrough status for Darzalex in earlier myeloma trea... Janssen's drug looking to gain bigger share in crowded myeloma market
News Janssen's Darzalex approved for myeloma in Europe Darzalex, a first-in-class treatment for multiple myeloma has been approved in Europe, adding to an increasingly competitive disease area.
News BMS and AbbVie’s myeloma drug Empliciti gains approval Multiple myeloma, one of the fastest-moving therapy areas, has just added another new treatment following FDA approval of Bristol-Myers Squibb's (BMS) and AbbVie's Empliciti (elotuzumab).
News Biogen, Denali pull Parkinson's drug after failed trial Biogen has stopped development of Denali-partnered Parkinson's disease candidate BIIB122, after it failed to move the needle in a phase 2b trial.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
